These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18346817)

  • 1. Central and peripheral administration of amylin induces energy expenditure in anesthetized rats.
    Osaka T; Tsukamoto A; Koyama Y; Inoue S
    Peptides; 2008 Jun; 29(6):1028-35. PubMed ID: 18346817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system.
    Osaka T; Endo M; Yamakawa M; Inoue S
    Peptides; 2005 Sep; 26(9):1623-31. PubMed ID: 16112402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute effect of amylin and salmon calcitonin on energy expenditure.
    Wielinga PY; Alder B; Lutz TA
    Physiol Behav; 2007 Jun; 91(2-3):212-7. PubMed ID: 17428511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats.
    Lutz TA; Rossi R; Althaus J; Del Prete E; Scharrer E
    Peptides; 1998; 19(9):1533-40. PubMed ID: 9864060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus.
    Haynes JM; Hodgson WC; Cooper ME
    Diabetologia; 1997 Mar; 40(3):256-61. PubMed ID: 9084962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.
    Mollet A; Gilg S; Riediger T; Lutz TA
    Physiol Behav; 2004 Mar; 81(1):149-55. PubMed ID: 15059694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of food intake and energy expenditure by amylin-therapeutic implications.
    Lutz TA
    Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S24-7. PubMed ID: 19363503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat.
    Olsson M; Herrington MK; Reidelberger RD; Permert J; Arnelo U
    Peptides; 2007 Jul; 28(7):1416-23. PubMed ID: 17614161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amylin acts in the central nervous system to increase sympathetic nerve activity.
    Fernandes-Santos C; Zhang Z; Morgan DA; Guo DF; Russo AF; Rahmouni K
    Endocrinology; 2013 Jul; 154(7):2481-8. PubMed ID: 23645151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central amylin acts as an adiposity signal to control body weight and energy expenditure.
    Wielinga PY; Löwenstein C; Muff S; Munz M; Woods SC; Lutz TA
    Physiol Behav; 2010 Aug; 101(1):45-52. PubMed ID: 20416330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amylin given by central and peripheral routes inhibits acid gastric secretion.
    Guidobono F; Coluzzi M; Pagani F; Pecile A; Netti C
    Peptides; 1994; 15(4):699-702. PubMed ID: 7937348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.
    Züger D; Forster K; Lutz TA; Riediger T
    Physiol Behav; 2013 Mar; 112-113():61-9. PubMed ID: 23438370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amylin is more potent and more effective than glucagon in raising plasma glucose concentration in fasted, anesthetized rats.
    Wang MW; Carlo P; Rink TJ; Young AA
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1288-93. PubMed ID: 1764079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does neuropeptide Y contribute to the anorectic action of amylin?
    Morris MJ; Nguyen T
    Peptides; 2001 Mar; 22(3):541-6. PubMed ID: 11287112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight.
    Mack CM; Soares CJ; Wilson JK; Athanacio JR; Turek VF; Trevaskis JL; Roth JD; Smith PA; Gedulin B; Jodka CM; Roland BL; Adams SH; Lwin A; Herich J; Laugero KD; Vu C; Pittner R; Paterniti JR; Hanley M; Ghosh S; Parkes DG
    Int J Obes (Lond); 2010 Feb; 34(2):385-95. PubMed ID: 19935749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of centrally injected amylin on sexually behavior of male rats.
    Clementi G; Busa L; de Bernardis E; Prato A; Drago F
    Peptides; 1999; 20(3):379-82. PubMed ID: 10447097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade.
    Hood SG; Watson AM; May CN
    Peptides; 2005 Jul; 26(7):1248-56. PubMed ID: 15949643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.
    Roth JD; Hughes H; Kendall E; Baron AD; Anderson CM
    Endocrinology; 2006 Dec; 147(12):5855-64. PubMed ID: 16935845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat.
    Clementi G; Caruso A; Cutuli VM; de Bernardis E; Prato A; Amico-Roxas M
    Experientia; 1996 Jul; 52(7):677-9. PubMed ID: 8698109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amylin: a novel action in the brain to reduce body weight.
    Rushing PA; Hagan MM; Seeley RJ; Lutz TA; Woods SC
    Endocrinology; 2000 Feb; 141(2):850-3. PubMed ID: 10650969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.